Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sara Rijjal"'
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Tamoxifen is one of the fundamental pillars of adjuvant endocrine therapy for hormone receptor-positive breast cancer; however, 30–50% of patients receiving tamoxifen experience tumor relapse. CYP2D6, encoded by an extremely pol
Externí odkaz:
https://doaj.org/article/7515b1162bc845188d5f5004b94aab7b
Autor:
Mousa Alali, Wouroud Ismail Al-khalil, Sara Rijjal, Lana Al-Salhi, Maher Saifo, Lama A. Youssef
Publikováno v:
Human Genomics, Vol 16, Iss 1, Pp 1-12 (2022)
Abstract CYP2D6 is a key drug-metabolizing enzyme implicated in the biotransformation of approximately 25% of currently prescribed drugs. Interindividual and interethnic differences in CYP2D6 enzymatic activity, and hence variability in substrate dru
Externí odkaz:
https://doaj.org/article/5acbd829c0bc4bc68ff5b5272f791af6
Autor:
Mousa Alali, Wouroud Ismail Al-khalil, Sara Rijjal, Lana Al-Salhi, Maher Saifo, Lama A. Youssef
Publikováno v:
Human Genomics, Vol 16, Iss 1, Pp 1-12 (2022)
Human Genomics
Human Genomics
CYP2D6 is a key drug-metabolizing enzyme implicated in the biotransformation of approximately 25% of currently prescribed drugs. Interindividual and interethnic differences in CYP2D6 enzymatic activity, and hence variability in substrate drug efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb2fc16909c5289fbb61616d0272fca7
https://pubmed.ncbi.nlm.nih.gov/35123571
https://pubmed.ncbi.nlm.nih.gov/35123571